ShangPharma Corporation (ShangPharma) is a China-based holding company. The Company is a pharmaceutical and biotechnology research and development (R&D) outsourcing company. It provides a range of high-quality, integrated services across the drug discovery and development process to international and Chinese pharmaceutical and biotechnology companies. Its services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. It offers its services on a full-time-equivalent (FTE) basis or a fee-for-service basis. The Company has a diversified and loyal global customer base. It provides services to over 100 customers, including pharmaceutical and biotechnology companies. In January 2011, the Company commenced operations at its Fengxian facility, which will operate as a wholly owned subsidiary under the name of China Gateway Pharmaceutical Development Co. Ltd.